| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962412 | Vaccine | 2016 | 9 Pages |
Abstract
This study provides reassuring evidence of the safety profile of TIIVs in SOT recipients, thus supporting current recommendations to vaccinate this risk group annually.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Gaël Dos Santos, François Haguinet, Catherine Cohet, Dave Webb, John Logie, Germano L.C. Ferreira, Dominique Rosillon, Vivek Shinde,